共 50 条
- [31] The risk of cardiac events among patients with systemic lupus erythematosus: comment on the article by Costenbader et al ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (03): : 476 - 476
- [33] Poly(ADP)-ribose polymerase and susceptibility to systemic lupus erythematosus and primary antiphospholipid syndrome: comment on the article by Delrieu et al ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1421 - 1422
- [34] Thrombovascular events in systemic lupus erythematosus: comment on the article by Jung et al ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2824 - 2824
- [35] Antibiotics in SAPHO syndrome: Comment on the article by Terui et al. JOURNAL OF DERMATOLOGY, 2024, 51 (01): : E25 - E25
- [37] Poly(ADP)-ribose polymerase and susceptibility to systemic lupus erythematosus and primary antiphospholipid syndrome: comment on the article by Delrieu et al - Reply ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1422 - 1423
- [38] Fetal cell trafficking and dermal fibrosis: Comment on the article by Christner et al - Reply ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2945 - 2945
- [39] Matrix metalloproteinase 9 in the saliva of patients with Sjogren's syndrome: comment on the article by Goicovich et al ARTHRITIS AND RHEUMATISM, 2004, 50 (07): : 2374 - 2374
- [40] Serious adverse events-missing in action: comment on the article by Kremer et al ARTHRITIS AND RHEUMATISM, 2012, 64 (09): : 3055 - 3056